You are viewing an incomplete version of our website. Please click to reload the website as full version.

Browse our anti-CDKN1B (CDKN1B) Antibodies

Full name:
anti-Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) Antibodies (CDKN1B)
On www.antibodies-online.com are 628 Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) Antibodies from 31 different suppliers available. Additionally we are shipping CDKN1B Kits (16) and CDKN1B Proteins (16) and many more products for this protein. A total of 714 CDKN1B products are currently listed.
Synonyms:
1500011J20Rik, 2610202L11Rik, AA408329, AI843786, Bridge-1, Cdki1b, cdkn1b, cdkn1bl, CDKN4, CIB, CIBP, FAM14D, ISG12, ISG12A, Kip1, MEN1B, MEN4, P27, P27KIP1, PRKDCIP, sb:cb611, SIP2-28, wu:fb63g10, wu:fb64g10, wu:fe18e03
list all antibodies Gene Name GeneID UniProt
CDKN1B 10519 Q99828
CDKN1B 12576 P46414
CDKN1B 83571  

Show all species

Show all synonyms

All available anti-CDKN1B Antibodies

Go to our pre-filtered search.

Top referenced anti-CDKN1B Antibodies

  1. Human Polyclonal CDKN1B Primary Antibody for IHC (p), WB - ABIN389617 : Wingate, Zhang, McGarhen, Bedrosian, Harper, Keyomarsi: The tumor-specific hyperactive forms of cyclin E are resistant to inhibition by p21 and p27. in The Journal of biological chemistry 2005 (PubMed)
    Show all 6 references for ABIN389617

  2. Human Polyclonal CDKN1B Primary Antibody for IHC (p), WB - ABIN389614 : Wang, Hou, Mohapatra, Ma, Cress, Pledger, Chen: Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism. in The Journal of biological chemistry 2005 (PubMed)
    Show all 6 references for ABIN389614

  3. Human Polyclonal CDKN1B Primary Antibody for EIA, IHC (p) - ABIN358183 : Kawamata, Inagaki, Mizumura, Sugimoto, Sakajiri, Ohyanagi-Hara, Oshimi: Methylation status analysis of cell cycle regulatory genes (p16INK4A, p15INK4B, p21Waf1/Cip1, p27Kip1 and p73) in natural killer cell disorders. in European journal of haematology 2005 (PubMed)
    Show all 5 references for ABIN358183

  4. Human Polyclonal CDKN1B Primary Antibody for EIA, IHC (p) - ABIN358184 : Mogensen, Shaw: Current approaches to unravel the mystery of dilated cardiomyopathy, a common cause of hereditary heart failure. in Expert review of proteomics 2005 (PubMed)
    Show all 5 references for ABIN358184

  5. Human Polyclonal CDKN1B Primary Antibody for EIA, IF - ABIN358766 : Andreu, Lledó, Poch, Ivorra, Albero, Martínez-Climent, Montiel-Duarte, Rifón, Pérez-Calvo, Arbona, Prósper, Pérez-Roger: BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. in Cancer research 2005 (PubMed)
    Show all 5 references for ABIN358766

  6. Human Polyclonal CDKN1B Primary Antibody for WB - ABIN2792168 : Azzato, Driver, Lesueur, Shah, Greenberg, Easton, Teschendorff, Caldas, Caporaso, Pharoah: Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. in Breast cancer research : BCR 2008 (PubMed)

  7. Cow (Bovine) Polyclonal CDKN1B Primary Antibody for EIA, WB - ABIN782873 : Toyoshima, Hunter: p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. in Cell 1994 (PubMed)

More Antibodies against CDKN1B Interaction Partners

Human Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. Data show that KDM5B (show KDM5B Antibodies) is frequently up-regulated in hepatocellular carcinoma tissues and cell lines and correlated with poor prognosis. Its depletion leads to highly impaired clonogenesis and cell cycle arrest through up-regulation of p15 (show CDKN2B Antibodies) and p27 (show PAK2 Antibodies).

  2. Estrogen-related receptor gamma (show ESRRG Antibodies) is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 (show CDKN1A Antibodies) and p27 (show PAK2 Antibodies).

  3. Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus is associated with Small Intestinal Neuroendocrine Tumors

  4. Results show that histological subtyping of pituitary tumor correlated with SSTR2 (show SSTR2 Antibodies), E cadherin (show CDH1 Antibodies) and p27kip protein levels and these may serve as useful biomarkers for prognosis.

  5. Clioquinol suppressed cell cycle progression in the S-phase in SMMC-7721 hepatoma cells via the p21 (show CDKN1A Antibodies), p27 (show PAK2 Antibodies)-cyclin E (show CCNE1 Antibodies),A/Cdk2 (show CDK2 Antibodies) pathway.

  6. results implicate Eya4 (show EYA4 Antibodies)/Six1 (show SIX1 Antibodies) regulates normal cardiac function via p27 (show PAK2 Antibodies)/casein kinase-2alpha/histone deacetylase 2 (show HDAC2 Antibodies) and indicate that mutations within this transcriptional complex and signaling cascade lead to the development of cardiomyopathy.

  7. Data show that cytoplasmic cyclin-dependent kinase inhibitor p27 is preferentially observed in primary non-small cell lung cancer (NSCLC) with activated proto-oncogene (show RAB1A Antibodies) proteins c-akt1 (show AKT1 Antibodies) and predicts poor survival.

  8. HDACIs increase p27(Kip1) by hampering its nuclear ubiquitination/degradation

  9. These findings provide evidence that miR (show MLXIP Antibodies)-24 has a tumor suppressor role in prostate cancer and also targets p27 (show PAK2 Antibodies) and p16 (show CDKN2A Antibodies) in prostate cancer cells

  10. IFI27 (show IFI27 Antibodies) mRNA level is reduced in peripheral blood mononuclear cells of immunoglobulin A nephropathy and membranous nephropathy patients.

Mouse (Murine) Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. The overexpression of p27 attenuates tumorigenicity by reducing proliferation and earlier loss of stemness of mouse induced pluripotent stem cells.

  2. p27(Kip1) and p21(Cip1 (show CDKN1A Antibodies)) are insufficient for the proliferative inhibition of smooth muscle cells cultured in type 1 collagen. honeycombs.

  3. results implicate Eya4 (show EYA4 Antibodies)/Six1 (show SIX1 Antibodies) regulates normal cardiac function via p27/casein kinase-2alpha/histone deacetylase 2 (show HDAC2 Antibodies) and indicate that mutations within this transcriptional complex and signaling cascade lead to the development of cardiomyopathy.

  4. Data indicate that a balance between supporting cell (show PTPRJ Antibodies) self-renewal and differentiation is maintained in the developing ovary by relative Wnt4 (show WNT4 Antibodies) protein/beta-catenin (show CTNNB1 Antibodies) and p27Kip1 protein (p27)/Forkhead box L2 (FOXL2 (show FOXL2 Antibodies)) activities.

  5. the p27 pathway may function downstream in the action of PTHrP (show PTHLH Antibodies) to regulate skeletal growth and development.

  6. Findings indicate that the Cdkn1b gene is positively regulated by a cis (show CISH Antibodies) element at the promoter of the adjacent Lockd locus, whereas the transcribed Lockd lncRNA is dispensable for this function.

  7. These results suggest that the abnormal expression of miR222 may contribute to dysregulation of the cellcycle in Alzheimer's disease, at least in part by affecting the expression of p27Kip1.

  8. Data demonstrate that the deletion of cyclin-dependent kinase inhibitor p27 (p27) in parathyroid hormone like hormone (Pthrp (show PTHLH Antibodies)) knock-in(KI/KI (show AXIN1 Antibodies)) mice can partially rescue defects in dental and mandibular development.

  9. Data indicate that an AMP (show TMPRSS5 Antibodies)-ctivated kinase (AMPK (show PRKAA1 Antibodies))/cell-cycle inhibitor (show CDKN2A Antibodies) p27KIP1 (p27) axis drives activation of autophagy in rapamycin-treated tuberous sclerosis 2 protein (Tsc2 (show TSC2 Antibodies))-null cells.

  10. Study shows that SGK1 (show SGK1 Antibodies) impairs nuclear abundance of p27 and suggests that phosphorylation of p27T197 by SGK1 (show SGK1 Antibodies) is required for cardiac hypertrophy.

Pig (Porcine) Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. FoxO1a (show FOXO1 Antibodies) can regulate p27kip nuclear localization

  2. the activation of Rac1 due to the cell-cell contact plays a critical role in the transcriptional up-regulation of p27Kip1 in vascular endothelial cells.

Cow (Bovine) Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

  1. p27Kip1 inhibition has an effect on proliferation of bovine corneal endothelial cells by RNA interferenc

Zebrafish Cyclin-Dependent Kinase Inhibitor 1B (p27, Kip1) (CDKN1B) interaction partners

CDKN1B Antigen Profile

Antigen Summary

Important regulator of cell cycle progression. Involved in G1 arrest. Potent inhibitor of cyclin E- and cyclin A-CDK2 complexes. Forms a complex with cyclin type D-CDK4 complexes and is involved in the assembly, stability, and modulation of CCND1- CDK4 complex activation. Acts either as an inhibitor or an activator of cyclin type D-CDK4 complexes depending on its phosphorylation state and/or stoichometry (By similarity).

Alternative names and synonyms associated with CDKN1B

  • cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B) antibody
  • calcium and integrin binding 1 (calmyrin) (CIB1) antibody
  • cyclin kinase inhibitor p30 Kip1 (LOC100689401) antibody
  • cyclin-dependent kinase inhibitor 1B (Cdkn1b) antibody
  • cyclin-dependent kinase inhibitor 1B (p27, Kip1) (Cdkn1b) antibody
  • cyclin-dependent kinase inhibitor 1Ba (cdkn1ba) antibody
  • cyclin-dependent kinase inhibitor 1Bb (cdkn1bb) antibody
  • interferon, alpha-inducible protein 27 (IFI27) antibody
  • proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 (Psmd9) antibody
  • 1500011J20Rik antibody
  • 2610202L11Rik antibody
  • AA408329 antibody
  • AI843786 antibody
  • Bridge-1 antibody
  • Cdki1b antibody
  • cdkn1b antibody
  • cdkn1bl antibody
  • CDKN4 antibody
  • CIB antibody
  • CIBP antibody
  • FAM14D antibody
  • ISG12 antibody
  • ISG12A antibody
  • Kip1 antibody
  • MEN1B antibody
  • MEN4 antibody
  • P27 antibody
  • P27KIP1 antibody
  • PRKDCIP antibody
  • sb:cb611 antibody
  • SIP2-28 antibody
  • wu:fb63g10 antibody
  • wu:fb64g10 antibody
  • wu:fe18e03 antibody

Protein level used designations for CDKN1B

cyclin-dependent kinase inhibitor 1B (p27, Kip1) , cyclin-dependent kinase inhibitor 1B , DNA-PK interaction protein , DNA-PKcs-interacting protein , DNA-dependent protein kinase interacting protein , SNK-interacting protein 2-28 , calcium and integrin-binding protein 1 , Cyclin-dependent kinase inhibitor p27 , cyclin-dependent kinase inhibitor p27 , Cyclin-dependent kinase inhibitor 1B (p27 Kip1) , Cyclin-dependent kinase inhibitor 1B (p27, Kip1) , cyclin-dependent kinase inhibitor p27/Kip1 , p27Kip1 , cyclin-dependent kinase inhibitor 1b, like , kip1 , p27 , cyclin-dependent kinase inhibitor 1b (p27, kip1) , fb64g10 , 2310061N23Rik , ISG12(a) , interferon alpha-induced 11.5 kDa protein , interferon alpha-inducible protein 27, mitochondrial , interferon-stimulated gene 12a protein , 26S proteasome non-ATPase regulatory subunit 9 , 26S proteasome regulatory subunit p27

GENE ID SPECIES
466947 Pan troglodytes
697188 Macaca mulatta
769872 Gallus gallus
100127219 Ovis aries
10519 Homo sapiens
100689401 Cricetulus griseus
12576 Mus musculus
83571 Rattus norvegicus
1027 Homo sapiens
403429 Canis lupus familiaris
374106 Gallus gallus
397584 Sus scrofa
512613 Bos taurus
100729359 Cavia porcellus
493958 Felis catus
402862 Danio rerio
368329 Danio rerio
3429 Homo sapiens
67151 Mus musculus
Selected quality suppliers for anti-CDKN1B (CDKN1B) Antibodies
Did you look for something else?